AzTrials
AzTrials

Suicidal ThoughtsPOPSNCT02855736

Positive Psychology in Suicidal Patients

A study testing Positive Psychology in people with Suicidal Thoughts and Suicidal Crisis, run by University Hospital, Montpellier at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Suicide is a major health concern. Weeks following psychiatric admission are a highly suicide risk period for those having current suicidal ideation or attempt. Recently, a pilot study suggested the feasibility of positive psychology in patients in suicidal crisis. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Suicidal Thoughts, Suicidal Crisis
What is being tested?
Positive Psychology
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
206 participants
Where
1 siteFrance
Study dates
Sep 2015to Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Being hospitalized for suicidal thoughts or suicide attempt (from less than a week)
  • Having signed informed consent
  • Be fluent in French
  • Able to understand nature, aims and methodology of the study

Who cannot join

  • Lifetime history of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders - V (DSM-V) criteria
  • Current eating disorder according to DSM-V criteria
  • Patient on protective measures (guardianship or trusteeship)
  • Deprived of liberty subject (judicial or administrative decision)

Trial locations and contacts

1 site in 1 country.

Déborah DUCASSE, MD PhD contact

+33 4 67 33 85 81

d-ducasse@chu-montpellier.fr

France1 site, 1 recruiting
  • Study site

    Montpellier, Hérault

    Catherine Genty, MD, +33 4 67 61 45 75, c-genty@chu-montpellier.fr

    Recruiting

Other trials in France

About this study

Official title: Effectiveness of Positive Psychology in Suicidal Patients: A Randomized Controlled Trial

Suicide is a major health concern. Weeks following psychiatric admission are a highly suicide risk period for those having current suicidal ideation or attempt. Recently, a pilot study suggested the feasibility of positive psychology in patients in suicidal crisis. Notably, gratitude exercises suggested improvement in optimism and hopelessness, two dimensions associated to suicide. Moreover, gratitude has been associated to suicidal ideation and attempt, independently from depression. Thus, investigators want to conduct the first randomized controlled study in order to assess effectiveness of gratitude exercises (vs control task) in suicidal inpatients, on 1) psychological pain reduction 2) suicidal ideation, hopelessness, optimism, depressive symptomatology, and anxiety improvement.

Read the detailed description

Study design: monocentric randomized controlled study

Methods:

206 inpatients (Department of Emergency Psychiatry and Post Acute Care), between 18 and 65 years-old, having attempted suicide before hospitalisation or having current active suicidal ideation at the time of the psychiatric hospitalisation. Patients suffering from schizophrenia are excluded.

Randomization into two groups: Positive Psychology (i.e., gratitude journal) (n = 103) or Control Task (i.e., food journal) (n = 103), daily exercises during 7 days (in add-on from usual treatment).

Clinical assessment: 1) at baseline (the day before the intervention beginning) (V0); 2) short daily self-assessments (immediately before and after the exercise); 3) the day following the last day of the intervention (V1).

  • V0 : socio-demographic data, treatments, psychopathology, suicidal ideation,depressive and anxious symptomatology, psychological pain, optimism, hopelessness.
  • Daily self-assessments: psychological pain, optimism, hopelessness
  • V1 : treatments suicidal ideation,depressive and anxious symptomatology, psychological pain, optimism, hopelessness, intervention satisfaction.
Being tested
Positive Psychology, Placebo (food journal)
Keywords
Suicidal inpatients, Positive Psychology, Gratitude, Psychological pain
Medical subject headings
Suicidal Ideation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Positive PsychologyBehavioural

    Gratitude Journal (Emmons and Stern, 2013)

    Every evening, patients have to write down the things they feel grateful about.

  • Placebo (food journal)Behavioural

    Food journal (i.e. alimentary list):

    Patients have to write down the list of foods eaten during the day.

Study groups in NCT02855736
Study groupRoleWhat they receive
Intervention groupExperimentalPositive Psychology (gratitude journal)
Receives: Behavioral: Positive Psychology
Control groupPlacebo comparatorAlimentary list
Receives: Behavioral: Placebo (food journal)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychological pain reduction using a likert scale

    Psychological pain reduction, in gratitude vs control group, between the beginning and the end of the intervention, using a likert scale.

    Measured: At the inclusion and day 8 (the day after the end of the intervention)

Secondary outcomes (10)
  1. Psychological pain reduction using a likert scale

    Psychological pain reduction, in gratitude vs control group, the beginning and the end of each exercise, using a likert scale.

    Measured: At day 1, 2, 3, 4, 5, 6, 7

  2. intensity of suicidal ideation

    Reduction of suicidal ideation intensity, in gratitude vs control group between the beginning and the end of the intervention using a Likert Scale and the Scale for Suicidal Ideation (SSI).

    Measured: At the inclusion and day 8 (the day after the end of the intervention)

  3. Intensity of hopelessness

    Reduction of hopelessness, in gratitude vs control group between the beginning and the end of the intervention, using a Likert Scale and the Beck Hopelessness Scale (BHS).

    Measured: At the inclusion and day 8 (the day after the end of the intervention)

  4. Intensity of optimism

    Reduction of hopelessness, in gratitude vs control group between the beginning and the end of the intervention, using a Likert Scale and the Life Orientation Test-Revised (LOT-R).

    Measured: At the inclusion and day 8 (the day after the end of the intervention)

  5. Intensity of depressive symptoms using the Beck Depression Inventory (BDI)

    Reduction of depressive symptoms between the beginning and the end of the intervention, using the Beck Depression Inventory (BDI)

    Measured: Day 8 (the day after the end of the intervention)

  6. Intensity of anxious symptoms using the State Anxiety Inventory- State (SAI-State)

    Reduction of anxious symptoms between the beginning and the end of the intervention, using the State Anxiety Inventory- State (SAI-State)

    Measured: Day 8 (the day after the end of the intervention)

  7. Perceived usefulness of the intervention using a likert scale

    Evaluation of the perceived usefulness of each intervention, using a likert scale.

    Measured: Day 8 (the day after the end of the intervention)

  8. Intensity of suicidal ideation

    Reduction of suicidal ideation intensity, in gratitude vs control group between the beginning and the end of each exercise, using a Likert Scale.

    Measured: At day 1, 2, 3,4 5, 6, 7

  9. Intensity of hopelessness

    Reduction of hopelessness, in gratitude vs control group between the beginning and the end of each exercise, using a Likert Scale.

    Measured: At day 1, 2, 3, 4, 5, 6, 7

  10. Intensity of optimism

    Reduction of hopelessness, in gratitude vs control group between the beginning and the end of each exercise, using a Likert Scale.

    Measured: At day 1, 2, 3, 4, 5, 6, 7

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2016 (estimated)
  2. Study startSep 2015
  3. Primary completionApr 2017 (estimated)
  4. Study completionJul 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
206 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02855736
Sponsor's protocol ID
UF 9557
Other IDs
2015-A00358-41
Acronym
POPS
Status last verified
Jul 2016
First submitted
8 Jul 2016
Last updated
4 Aug 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Positive Psychology in people with Suicidal Thoughts and Suicidal Crisis, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Déborah DUCASSE, MD PhD (+33 4 67 33 85 81, d-ducasse@chu-montpellier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Psychological pain reduction using a likert scale (time frame: At the inclusion and day 8 (the day after the end of the intervention)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in